BIAF · bioAffinity Technologies, Inc.
AI read · Good for BIAF
The AI's read
More doctors ordering the test can widen its reach and build repeat use. The company also expanded its sales team and is working on possible uses in asthma and COPD. A published study reported promising results in a defined high-risk group, but the test is meant to be used with other clinical findings. Test counts do not show how much sales or profit they brought in.